United States Kinase Inhibitors Market Report 2017

December 2017 | 104 pages | ID: U8B3543F42EEN
QYResearch

Abstracts

In this report, the United States Kinase Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Kinase Inhibitors in these regions, from 2012 to 2022 (forecast).

United States Kinase Inhibitors market competition by top manufacturers/players, with Kinase Inhibitors sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Boehringer Ingelheim
• Cytrx Corporation
• Eton Bioscience Inc.
• Glaxosmithkline
• Bristol-Myers Squibb
• Osi Pharmaceuticals Llc
• Pfizer
• Eisai Inc.
• Merck Serono Sa
• Novartis International Ag

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tyrosin Kinase Inhibitors (TKI)
• Receptor Tyrosine Kinase Inhibitors
• Non-Receptor Tyrosine Kinase Inhibitors
• Mulikinase Inhibitors
• Threonine Kinase Inhibitors
• mTOR Kinase Inhibitors
• RHO Kinase Inhibitors
• Cyclin Dependant Kinase Inhibitors
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pharmaceutical
• Health Care Products
• Scientific Research

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Kinase Inhibitors Market Report 2017

1 KINASE INHIBITORS OVERVIEW

1.1 Product Overview and Scope of Kinase Inhibitors
1.2 Classification of Kinase Inhibitors by Product Category
  1.2.1 United States Kinase Inhibitors Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Kinase Inhibitors Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tyrosin Kinase Inhibitors (TKI)
  1.2.4 Receptor Tyrosine Kinase Inhibitors
  1.2.5 Non-Receptor Tyrosine Kinase Inhibitors
  1.2.6 Mulikinase Inhibitors
  1.2.7 Threonine Kinase Inhibitors
  1.2.8 mTOR Kinase Inhibitors
  1.2.9 RHO Kinase Inhibitors
  1.2.10 Cyclin Dependant Kinase Inhibitors
  1.2.11 Others
1.3 United States Kinase Inhibitors Market by Application/End Users
  1.3.1 United States Kinase Inhibitors Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pharmaceutical
  1.3.3 Health Care Products
  1.3.4 Scientific Research
1.4 United States Kinase Inhibitors Market by Region
  1.4.1 United States Kinase Inhibitors Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Kinase Inhibitors Status and Prospect (2012-2022)
  1.4.3 Southwest Kinase Inhibitors Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Kinase Inhibitors Status and Prospect (2012-2022)
  1.4.5 New England Kinase Inhibitors Status and Prospect (2012-2022)
  1.4.6 The South Kinase Inhibitors Status and Prospect (2012-2022)
  1.4.7 The Midwest Kinase Inhibitors Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Kinase Inhibitors (2012-2022)
  1.5.1 United States Kinase Inhibitors Sales and Growth Rate (2012-2022)
  1.5.2 United States Kinase Inhibitors Revenue and Growth Rate (2012-2022)

2 UNITED STATES KINASE INHIBITORS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Kinase Inhibitors Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Kinase Inhibitors Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Kinase Inhibitors Average Price by Players/Suppliers (2012-2017)
2.4 United States Kinase Inhibitors Market Competitive Situation and Trends
  2.4.1 United States Kinase Inhibitors Market Concentration Rate
  2.4.2 United States Kinase Inhibitors Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Kinase Inhibitors Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES KINASE INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Kinase Inhibitors Sales and Market Share by Region (2012-2017)
3.2 United States Kinase Inhibitors Revenue and Market Share by Region (2012-2017)
3.3 United States Kinase Inhibitors Price by Region (2012-2017)

4 UNITED STATES KINASE INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Kinase Inhibitors Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Kinase Inhibitors Revenue and Market Share by Type (2012-2017)
4.3 United States Kinase Inhibitors Price by Type (2012-2017)
4.4 United States Kinase Inhibitors Sales Growth Rate by Type (2012-2017)

5 UNITED STATES KINASE INHIBITORS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Kinase Inhibitors Sales and Market Share by Application (2012-2017)
5.2 United States Kinase Inhibitors Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES KINASE INHIBITORS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Kinase Inhibitors Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boehringer Ingelheim Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cytrx Corporation
  6.2.2 Kinase Inhibitors Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cytrx Corporation Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eton Bioscience Inc.
  6.3.2 Kinase Inhibitors Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eton Bioscience Inc. Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Glaxosmithkline
  6.4.2 Kinase Inhibitors Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Glaxosmithkline Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Kinase Inhibitors Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Osi Pharmaceuticals Llc
  6.6.2 Kinase Inhibitors Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Osi Pharmaceuticals Llc Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Kinase Inhibitors Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eisai Inc.
  6.8.2 Kinase Inhibitors Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eisai Inc. Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck Serono Sa
  6.9.2 Kinase Inhibitors Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Serono Sa Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis International Ag
  6.10.2 Kinase Inhibitors Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis International Ag Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 KINASE INHIBITORS MANUFACTURING COST ANALYSIS

7.1 Kinase Inhibitors Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Kinase Inhibitors

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Kinase Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Kinase Inhibitors Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES KINASE INHIBITORS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Kinase Inhibitors Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Kinase Inhibitors Sales Volume Forecast by Type (2017-2022)
11.3 United States Kinase Inhibitors Sales Volume Forecast by Application (2017-2022)
11.4 United States Kinase Inhibitors Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Kinase Inhibitors
Figure United States Kinase Inhibitors Market Size (K MT) by Type (2012-2022)
Figure United States Kinase Inhibitors Sales Volume Market Share by Type (Product Category) in 2016
Figure Tyrosin Kinase Inhibitors (TKI) Product Picture
Figure Receptor Tyrosine Kinase Inhibitors Product Picture
Figure Non-Receptor Tyrosine Kinase Inhibitors Product Picture
Figure Mulikinase Inhibitors Product Picture
Figure Threonine Kinase Inhibitors Product Picture
Figure mTOR Kinase Inhibitors Product Picture
Figure RHO Kinase Inhibitors Product Picture
Figure Cyclin Dependant Kinase Inhibitors Product Picture
Figure Others Product Picture
Figure United States Kinase Inhibitors Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Kinase Inhibitors by Application in 2016
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Health Care Products Examples
Table Key Downstream Customer in Health Care Products
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure United States Kinase Inhibitors Market Size (Million USD) by Region (2012-2022)
Figure The West Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Kinase Inhibitors Sales (K MT) and Growth Rate (2012-2022)
Figure United States Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Kinase Inhibitors Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Kinase Inhibitors Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Kinase Inhibitors Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Kinase Inhibitors Sales Share by Players/Suppliers
Figure 2017 United States Kinase Inhibitors Sales Share by Players/Suppliers
Figure United States Kinase Inhibitors Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Kinase Inhibitors Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Kinase Inhibitors Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Kinase Inhibitors Revenue Share by Players/Suppliers
Figure 2017 United States Kinase Inhibitors Revenue Share by Players/Suppliers
Table United States Market Kinase Inhibitors Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Kinase Inhibitors Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Kinase Inhibitors Market Share of Top 3 Players/Suppliers
Figure United States Kinase Inhibitors Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Kinase Inhibitors Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Kinase Inhibitors Product Category
Table United States Kinase Inhibitors Sales (K MT) by Region (2012-2017)
Table United States Kinase Inhibitors Sales Share by Region (2012-2017)
Figure United States Kinase Inhibitors Sales Share by Region (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Region in 2016
Table United States Kinase Inhibitors Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Kinase Inhibitors Revenue Share by Region (2012-2017)
Figure United States Kinase Inhibitors Revenue Market Share by Region (2012-2017)
Figure United States Kinase Inhibitors Revenue Market Share by Region in 2016
Table United States Kinase Inhibitors Price (USD/MT) by Region (2012-2017)
Table United States Kinase Inhibitors Sales (K MT) by Type (2012-2017)
Table United States Kinase Inhibitors Sales Share by Type (2012-2017)
Figure United States Kinase Inhibitors Sales Share by Type (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Type in 2016
Table United States Kinase Inhibitors Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Kinase Inhibitors Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Kinase Inhibitors by Type (2012-2017)
Figure Revenue Market Share of Kinase Inhibitors by Type in 2016
Table United States Kinase Inhibitors Price (USD/MT) by Types (2012-2017)
Figure United States Kinase Inhibitors Sales Growth Rate by Type (2012-2017)
Table United States Kinase Inhibitors Sales (K MT) by Application (2012-2017)
Table United States Kinase Inhibitors Sales Market Share by Application (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Application (2012-2017)
Figure United States Kinase Inhibitors Sales Market Share by Application in 2016
Table United States Kinase Inhibitors Sales Growth Rate by Application (2012-2017)
Figure United States Kinase Inhibitors Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Cytrx Corporation Basic Information List
Table Cytrx Corporation Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cytrx Corporation Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Cytrx Corporation Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Cytrx Corporation Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Eton Bioscience Inc. Basic Information List
Table Eton Bioscience Inc. Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eton Bioscience Inc. Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Eton Bioscience Inc. Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Eton Bioscience Inc. Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Glaxosmithkline Basic Information List
Table Glaxosmithkline Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Glaxosmithkline Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Glaxosmithkline Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Glaxosmithkline Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Osi Pharmaceuticals Llc Basic Information List
Table Osi Pharmaceuticals Llc Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Osi Pharmaceuticals Llc Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Osi Pharmaceuticals Llc Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Osi Pharmaceuticals Llc Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Pfizer Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Pfizer Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Eisai Inc. Basic Information List
Table Eisai Inc. Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eisai Inc. Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Eisai Inc. Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Eisai Inc. Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Merck Serono Sa Basic Information List
Table Merck Serono Sa Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Serono Sa Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Merck Serono Sa Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Merck Serono Sa Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Novartis International Ag Basic Information List
Table Novartis International Ag Kinase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis International Ag Kinase Inhibitors Sales Growth Rate (2012-2017)
Figure Novartis International Ag Kinase Inhibitors Sales Market Share in United States (2012-2017)
Figure Novartis International Ag Kinase Inhibitors Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kinase Inhibitors
Figure Manufacturing Process Analysis of Kinase Inhibitors
Figure Kinase Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Kinase Inhibitors Major Players/Suppliers in 2016
Table Major Buyers of Kinase Inhibitors
Table Distributors/Traders List
Figure United States Kinase Inhibitors Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Kinase Inhibitors Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Kinase Inhibitors Price (USD/MT) Trend Forecast (2017-2022)
Table United States Kinase Inhibitors Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Type in 2022
Table United States Kinase Inhibitors Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Kinase Inhibitors Sales Volume (K MT) Forecast by Application in 2022
Table United States Kinase Inhibitors Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Kinase Inhibitors Sales Volume Share Forecast by Region (2017-2022)
Figure United States Kinase Inhibitors Sales Volume Share Forecast by Region (2017-2022)
Figure United States Kinase Inhibitors Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources